source
- FDA plans study on barriers to women's enrollment in pregnancy exposure registries and announces PRV fee ratesThe Food and Drug Administration said it will conduct research into perceived barriers that limit women’s participation in pregnancy exposure registries. It also released the fee schedule for prio…
- Alloy Therapeutics appoints Venkat Krishnamurthy as chief scientific officer of genetic medicines unitAlloy Therapeutics announced the hiring of Venkat Krishnamurthy as chief scientific officer for its genetic medicines division. Krishnamurthy previously held the same role at Flashpoint Therapeuti…